BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34422708)

  • 21. Isolated ileal blind loop inflammation after intestinal resection with ileocolonic anastomosis in Crohn's disease: an often neglected endoscopic finding with an unfavorable outcome.
    Beelen EMJ; de Vries AC; Bodelier AG; Moolenaar J; Schouten WR; van der Woude CJ
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1370-1375. PubMed ID: 31567617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study.
    Fumery M; Pariente B; Sarter H; Savoye G; Spyckerelle C; Djeddi D; Mouterde O; Bouguen G; Ley D; Peneau A; Dupas JL; Turck D; Gower-Rousseau C;
    Dig Liver Dis; 2019 Apr; 51(4):496-502. PubMed ID: 30611597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the initial location of Crohn's disease have an influence on the time-to-relapse in patients under maintenance treatment with oral mesalamine?
    Bresci G; Parisi G; Bertoni M; Masolino P; Scatena F; Capria A
    J Clin Gastroenterol; 2000 Sep; 31(2):147-51. PubMed ID: 10993432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study.
    Samimi R; Flasar MH; Kavic S; Tracy K; Cross RK
    Inflamm Bowel Dis; 2010 Jul; 16(7):1187-94. PubMed ID: 19902541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
    Riss S; Schuster I; Papay P; Mittlböck M; Stift A
    Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.
    Smith BR; Arnott ID; Drummond HE; Nimmo ER; Satsangi J
    Inflamm Bowel Dis; 2004 Sep; 10(5):521-8. PubMed ID: 15472511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the incidence of early endoscopic recurrence after ileocolonic resection for Crohn's disease: a multicentre observational study.
    de Barcelos IF; Kotze PG; Spinelli A; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; da Silva Kotze LM; Yamamoto T
    Colorectal Dis; 2017 Jan; 19(1):O39-O45. PubMed ID: 27943564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium.
    Lazarev M; Huang C; Bitton A; Cho JH; Duerr RH; McGovern DP; Proctor DD; Regueiro M; Rioux JD; Schumm PP; Taylor KD; Silverberg MS; Steinhart AH; Hutfless S; Brant SR
    Am J Gastroenterol; 2013 Jan; 108(1):106-12. PubMed ID: 23229423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant colonic disease (Montreal L3) and re-resectional surgery are predictors of clinical recurrence following ileocolonic resection for Crohn's disease.
    Morar PS; Faiz O; Hodgkinson JD; Zafar N; Koysombat K; Purcell M; Hart A; Warusavitarne J
    Colorectal Dis; 2015 Nov; 17(11):O247-55. PubMed ID: 26291699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.
    Hong SW; Ye BD; Cheon JH; Lee JH; Koo JS; Jang BI; Lee KM; Kim YS; Kim TO; Im JP; Song GA; Jung SA; Kim HS; Park DI; Kim HS; Huh KC; Kim YH; Cha JM; Seo GS; Choi CH; Song HJ; Baik GH; Kim JW; Shin SJ; Park YS; Lee CK; Lee J; Jung SH; Jung Y; Park SC; Joo YE; Jeen YT; Han DS; Yang SK; Kim HJ; Kim WH; Kim JS
    Gut Liver; 2022 Nov; 16(6):907-920. PubMed ID: 35321956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colonic phenotype of the ileum in Crohn's disease: a prospective study before and after ileocolonic resection.
    Ascolani M; Mescoli C; Palmieri G; Sica G; Calabrese E; Petruzziello C; Onali S; Albertoni L; Lolli E; Condino G; Pallone F; Rugge M; Biancone L
    Inflamm Bowel Dis; 2014 Sep; 20(9):1555-61. PubMed ID: 25054336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort study.
    Atia O; Goren I; Fischler TS; Weisband YL; Greenfeld S; Kariv R; Ledderman N; Matz E; Rimon RM; Dotan I; Turner D; Yanai H
    Aliment Pharmacol Ther; 2023 May; 57(9):1004-1013. PubMed ID: 36894866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.
    Song XM; Gao X; Li MZ; Chen ZH; Chen SC; Hu PJ; He YL; Zhan WH; Chen MH
    Dis Colon Rectum; 2011 Sep; 54(9):1147-54. PubMed ID: 21825896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Naidoo K; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life after ileocolonic resection for Crohn's disease: long-term results.
    Scarpa M; Ruffolo C; D'Incà R; Filosa T; Bertin E; Ferraro S; Polese L; Martin A; Sturniolo GC; Frego M; D'Amico DF; Angriman I
    Inflamm Bowel Dis; 2007 Apr; 13(4):462-9. PubMed ID: 17206691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization.
    Geem D; Hercules D; Pelia RS; Venkateswaran S; Griffiths A; Noe JD; Dotson JL; Snapper S; Rabizadeh S; Rosh JR; Baldassano RN; Markowitz JF; Walters TD; Ananthakrishnan A; Sharma G; Denson LA; Hyams JS; Kugathasan S
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):368-376.e4. PubMed ID: 37802268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
    Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA
    Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.